General Archive
-
News releasesGOSH Charity and LifeArc launch £1M grant scheme
Great Ormond Street Hospital Children’s Charity (GOSH Charity) and LifeArc, a leading UK medical research charity, today announce the launch…
-
News releasesLifeArc and C4X Discovery join forces to develop small molecule drug candidates
LifeArc and C4X Discovery join forces to develop small molecule drug candidates active against a high value, novel oncology and…
-
News releasesLifeArc® and Asthma UK® announce collaboration
LifeArc, a medical research charity, has signed an agreement to review Asthma UK’s research portfolio, aiming to identify promising projects…
-
News releasesLifeArc appoints new Head of IP
LifeArc is delighted to announce the appointment of Diana Sternfeld as its new Head of Intellectual Property (IP), effective 12th…
-
News releasesLifeArc Diagnostics Centre achieves medical device certification within one year of opening
LifeArc®, one of the UK’s leading medical research charities, proudly announces that its Centre for Diagnostic Development (CDD) has just…
-
News releasesInnovative diagnostic test for tuberculosis could save millions of lives
Lifearc® the medical research charity, and The University of St Andrews Infection Group today announced a partnership to develop a molecular…
-
News releases
LifeArc appoints Head of Seed Funds
David Holbrook has been appointed to manage our newly created Seed Fund. The £25m fund will invest in innovative early…
-
News releases
CEO Dave Tapolczay stepping down
Dave Tapolczay, Chief Executive Officer, LifeArc, has announced his intention to step down after 10 years in the role. Under…
-
News releases
LifeArc announces £5M support for rare disease research
LifeArc®, the medical research charity, today announced its Philanthropic Fund will award £5M in grants to support medical research projects…
-
News releasesNew partnership in artificial intelligence and machine learning for target discovery announced
New LifeArc®/Milner Therapeutics Institute partnership use machine learning to identify and validate new drug targets in immuno-oncology and respiratory diseases.
-
News releasesPartnership with TetraGenetics targets Type 1 diabetes
New partnership hopes to accelerate the development of a cure for Type 1 Diabetes.
-
News releasesLifeArc appointments strengthen board of trustees
LifeArc has strengthened its board by appointing three new trustees.